BioLife Solutions (BLFS) Competitors $24.11 -0.60 (-2.43%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. SLNO, IRTC, TMDX, PRCT, NVST, LMAT, LIVN, ENOV, NVCR, and CNMDShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular LivaNova Enovis NovoCure CONMED Soleno Therapeutics (NASDAQ:SLNO) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Do institutionals and insiders believe in SLNO or BLFS? 97.4% of Soleno Therapeutics shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 12.3% of Soleno Therapeutics shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts recommend SLNO or BLFS? Soleno Therapeutics currently has a consensus target price of $104.67, indicating a potential upside of 39.82%. BioLife Solutions has a consensus target price of $31.17, indicating a potential upside of 29.27%. Given Soleno Therapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Soleno Therapeutics is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SLNO or BLFS more profitable? Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -38.98%. BioLife Solutions' return on equity of -6.61% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Soleno TherapeuticsN/A -61.99% -55.21% BioLife Solutions -38.98%-6.61%-5.54% Does the media refer more to SLNO or BLFS? In the previous week, Soleno Therapeutics had 7 more articles in the media than BioLife Solutions. MarketBeat recorded 12 mentions for Soleno Therapeutics and 5 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 1.71 beat Soleno Therapeutics' score of 1.23 indicating that BioLife Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Soleno Therapeutics 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better earnings and valuation, SLNO or BLFS? Soleno Therapeutics has higher earnings, but lower revenue than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoleno TherapeuticsN/AN/A-$38.99M-$4.26-17.57BioLife Solutions$82.25M13.92-$66.43M-$0.50-48.22 Does the MarketBeat Community prefer SLNO or BLFS? Soleno Therapeutics received 9 more outperform votes than BioLife Solutions when rated by MarketBeat users. Likewise, 72.62% of users gave Soleno Therapeutics an outperform vote while only 66.95% of users gave BioLife Solutions an outperform vote. CompanyUnderperformOutperformSoleno TherapeuticsOutperform Votes32172.62% Underperform Votes12127.38% BioLife SolutionsOutperform Votes31266.95% Underperform Votes15433.05% Which has more risk & volatility, SLNO or BLFS? Soleno Therapeutics has a beta of -2.29, meaning that its share price is 329% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. SummarySoleno Therapeutics beats BioLife Solutions on 12 of the 18 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.15B$3.21B$5.57B$7.82BDividend YieldN/A1.80%5.11%4.22%P/E Ratio-22.7515.4222.4218.48Price / Sales13.9252.69394.10103.91Price / CashN/A44.0938.1834.62Price / Book3.143.526.774.25Net Income-$66.43M$94.03M$3.22B$248.23M7 Day Performance-0.99%3.95%3.26%3.29%1 Month Performance-7.13%2.12%0.02%2.42%1 Year Performance37.46%-16.43%18.01%5.54% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.5584 of 5 stars$24.11-2.4%$31.17+29.3%+37.5%$1.15B$82.25M-22.75440Positive NewsSLNOSoleno Therapeutics4.6455 of 5 stars$68.93-1.5%$99.63+44.5%+67.6%$3.16BN/A-20.7630Upcoming EarningsPositive NewsIRTCiRhythm Technologies0.9754 of 5 stars$98.63-2.3%$119.73+21.4%-2.5%$3.10B$591.84M-27.101,790Upcoming EarningsNews CoveragePositive NewsTMDXTransMedics Group3.0331 of 5 stars$87.72-0.6%$122.70+39.9%-2.3%$2.97B$441.54M93.32210Analyst ForecastGap DownPRCTPROCEPT BioRobotics2.7239 of 5 stars$53.43+0.8%$91.43+71.1%+1.9%$2.93B$224.50M-27.40430Earnings ReportAnalyst RevisionPositive NewsHigh Trading VolumeNVSTEnvista4.4284 of 5 stars$14.88-2.0%$19.96+34.2%-18.3%$2.56B$2.51B-2.2912,700Analyst ForecastLMATLeMaitre Vascular2.166 of 5 stars$84.72-1.8%$95.25+12.4%+40.0%$1.91B$219.86M46.30490Upcoming EarningsPositive NewsLIVNLivaNova3.8183 of 5 stars$34.61-2.7%$61.17+76.7%-33.6%$1.88B$1.25B82.402,900Upcoming EarningsNews CoveragePositive NewsENOVEnovis2.7286 of 5 stars$32.25+0.9%$58.50+81.4%-37.4%$1.84B$2.11B-14.736,800News CoveragePositive NewsNVCRNovoCure3.7362 of 5 stars$15.58flat$34.17+119.3%+48.2%$1.71B$605.22M-11.131,320Earnings ReportCNMDCONMED4.5996 of 5 stars$47.71-1.8%$77.20+61.8%-28.1%$1.48B$1.31B11.254,100Earnings ReportAnalyst DowngradeNews Coverage Related Companies and Tools Related Companies Soleno Therapeutics Competitors iRhythm Technologies Competitors TransMedics Group Competitors PROCEPT BioRobotics Competitors Envista Competitors LeMaitre Vascular Competitors LivaNova Competitors Enovis Competitors NovoCure Competitors CONMED Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLFS Stock Free BLFS Stock Alerts